Evaluation of tumor response to immune checkpoint inhibitors by a 3D immunotumoroid model
BackgroundOnly 20 percent of renal and bladder cancer patients will show a significant response to immune checkpoint inhibitor (ICI) therapy, and no test currently available accurately predicts ICI response.MethodsWe developed an “immunotumoroid” cell …